Royal Bank of Canada’s Thermo Fisher Scientific TMO Stock Holding History

Royal Bank of Canada’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.69M	Hold	7,500	–	–	﹤0.01%	2641
2025 Q4	$4.35M	Buy	+7,500	New	+$4.24M	﹤0.01%	2536
2025 Q3	–	Sell	-75,000	Closed	-$30.4M	–	7530
2025 Q2	$30.4M	Buy	+75,000	New	+$31.4M	0.01%	1233
2024 Q4	–	Sell	-82,000	Closed	-$50.7M	–	7251
2024 Q3	$50.7M	Buy	+82,000	New	+$48.5M	0.01%	814
2023 Q4	–	Sell	-10,500	Closed	-$5.32M	–	7584
2023 Q3	$5.32M	Buy	+10,500	New	+$5.6M	﹤0.01%	2042
2023 Q2	–	Sell	-10,500	Closed	-$6.05M	–	7664
2023 Q1	$6.05M	Buy	+10,500	New	+$5.92M	﹤0.01%	1927
2021 Q3	–	Sell	-6,400	Closed	-$3.23M	–	7872
2021 Q2	$3.23M	Buy	+6,400	New	+$3.02M	﹤0.01%	2642
2021 Q1	–	Sell	-33,500	Closed	-$15.6M	–	7699
2020 Q4	$15.6M	Buy	+33,500	New	+$15.7M	﹤0.01%	1412
2019 Q4	–	Sell	-52,000	Closed	-$15.1M	–	7116
2019 Q3	$15.1M	Buy	+52,000	New	+$14.9M	0.01%	1255
2017 Q3	–	Sell	-14,600	Closed	-$2.55M	–	6977
2017 Q2	$2.55M	Buy	+14,600	New	+$2.45M	﹤0.01%	2403
2014 Q2	–	Sell	-70,000	Closed	-$8.42M	–	6128
2014 Q1	$8.42M	Buy	+70,000	New	+$8.32M	0.01%	1252
2013 Q3	–	Sell	-15,000	Closed	-$1.27M	–	6253
2013 Q2	$1.27M	Buy	+15,000	New	+$1.25M	﹤0.01%	2400

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada's TMO Position: Q1 2026 in Review

Royal Bank of Canada reduced its Thermo Fisher Scientific (TMO) stake by 3% in Q1 2026, selling an estimated $66.4M and leaving 3,913,903 shares worth $1.92B. The position accounts for 0.34% of the portfolio, ranked #56.

Royal Bank of Canada first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.47B in Q2 2023. 2,596 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Royal Bank of Canada held 3,913,903 shares of Thermo Fisher Scientific worth $1.92B as of Q1 2026.
Royal Bank of Canada sold 122,343 Thermo Fisher Scientific shares in Q1 2026, an estimated $66.4M.
Thermo Fisher Scientific made up 0.34% of Royal Bank of Canada's portfolio in Q1 2026, its #56 holding.
Royal Bank of Canada first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
Royal Bank of Canada's Thermo Fisher Scientific position peaked at $2.47B in Q2 2023.
2,596 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.